Insights on the Neurointervention Flow-diverting Stent Market Report & Forecast to 2028 - by Players, Types, Applications and Region
QYResearch released a latest market research report on the Global and United States Neurointervention Flow-diverting Stent market, which is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the Global Neurointervention Flow-diverting Stent market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
Scope of the Neurointervention Flow-diverting Stent Market Report
Due to the COVID-19 pandemic, the global Neurointervention Flow-diverting Stent market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Recyclable accounting for % of the Neurointervention Flow-diverting Stent global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Hospital was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
Global Neurointervention Flow-diverting Stent Scope and Market Size
Neurointervention Flow-diverting Stent market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Neurointervention Flow-diverting Stent market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Neurointervention Flow-diverting Stent market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
For more information about this report, visit
Key Questions Answered in This Report
How has the Global and United States Neurointervention Flow-diverting Stent performed so far and how will it perform in the coming years?
What are the key regional markets?
What is the breakup of the market based on the Neurointervention Flow-diverting Stent type?
What is the breakup of the market based on the application?
What is the breakup of the market size based on the region?
What is the breakup of the market based on the region Level & country Level?
Who are the key players of the Global and United States Neurointervention Flow-diverting Stent?
Segments Covered in the Report
Segment by Type
Recyclable
Not Recyclable
Segment by Application
Hospital
Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Medtronic
Balt
Stryker
MicroVention
Phenox GmbH
MicroPort NeuroTech
Skynor Medical
AccuMedical
NowYon Medical
Key Topics Covered
1 Study Coverage
2 Market by Type
3 Market by Application
4 Global Neurointervention Flow-diverting Stent Competitor Landscape by Company
5 Global Neurointervention Flow-diverting Stent Market Size by Region
6 Segment in Region Level & Country Level
7 Company Profiles
7.1 Medtronic
7.1.1 Medtronic Corporation Information
7.1.2 Medtronic Description and Business Overview
7.1.3 Medtronic Neurointervention Flow-diverting Stent Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Medtronic Neurointervention Flow-diverting Stent Products Offered
7.1.5 Medtronic Recent Development
7.2 Balt
7.2.1 Balt Corporation Information
7.2.2 Balt Description and Business Overview
7.2.3 Balt Neurointervention Flow-diverting Stent Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Balt Neurointervention Flow-diverting Stent Products Offered
7.2.5 Balt Recent Development
7.3 Stryker
7.3.1 Stryker Corporation Information
7.3.2 Stryker Description and Business Overview
7.3.3 Stryker Neurointervention Flow-diverting Stent Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Stryker Neurointervention Flow-diverting Stent Products Offered
7.3.5 Stryker Recent Development
7.4 MicroVention
7.4.1 MicroVention Corporation Information
7.4.2 MicroVention Description and Business Overview
7.4.3 MicroVention Neurointervention Flow-diverting Stent Sales, Revenue and Gross Margin (2017-2022)
7.4.4 MicroVention Neurointervention Flow-diverting Stent Products Offered
7.4.5 MicroVention Recent Development
7.5 Phenox GmbH
7.5.1 Phenox GmbH Corporation Information
7.5.2 Phenox GmbH Description and Business Overview
7.5.3 Phenox GmbH Neurointervention Flow-diverting Stent Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Phenox GmbH Neurointervention Flow-diverting Stent Products Offered
7.5.5 Phenox GmbH Recent Development
7.6 MicroPort NeuroTech
7.6.1 MicroPort NeuroTech Corporation Information
7.6.2 MicroPort NeuroTech Description and Business Overview
7.6.3 MicroPort NeuroTech Neurointervention Flow-diverting Stent Sales, Revenue and Gross Margin (2017-2022)
7.6.4 MicroPort NeuroTech Neurointervention Flow-diverting Stent Products Offered
7.6.5 MicroPort NeuroTech Recent Development
7.7 Skynor Medical
7.7.1 Skynor Medical Corporation Information
7.7.2 Skynor Medical Description and Business Overview
7.7.3 Skynor Medical Neurointervention Flow-diverting Stent Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Skynor Medical Neurointervention Flow-diverting Stent Products Offered
7.7.5 Skynor Medical Recent Development
7.8 AccuMedical
7.8.1 AccuMedical Corporation Information
7.8.2 AccuMedical Description and Business Overview
7.8.3 AccuMedical Neurointervention Flow-diverting Stent Sales, Revenue and Gross Margin (2017-2022)
7.8.4 AccuMedical Neurointervention Flow-diverting Stent Products Offered
7.8.5 AccuMedical Recent Development
7.9 NowYon Medical
7.9.1 NowYon Medical Corporation Information
7.9.2 NowYon Medical Description and Business Overview
7.9.3 NowYon Medical Neurointervention Flow-diverting Stent Sales, Revenue and Gross Margin (2017-2022)
7.9.4 NowYon Medical Neurointervention Flow-diverting Stent Products Offered
7.9.5 NowYon Medical Recent Development
8 Industry Chain and Sales Channels Analysis
9 Research Findings and Conclusion
For more information about this report, visit
Any questions or requirements, please do not hesitate to contact us.
About Us:
QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 15 years’ experience and professional research team in various cities over the world，QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 59,000 clients across five continents. Let’s work closely with you and build a bold and better future.
Contact Us
QY Research
E-mail: global@qyresearch.com
Tel: +1-626-842-1666(US) +852-5808-0956 (HK)
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
Website: https://us.qyresearch.com